Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis

BACKGROUND: Molnupiravir is an essential oral antiviral agent against coronavirus disease 2019 (COVID-19); however, its real-world effectiveness has not been evaluated in patients undergoing haemodialysis (HD). METHODS: This multi-centre retrospective study, involving 225 patients undergoing HD with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yi-Chin, Chen, Yi-Chun, Huang, Chiang-Chi, Fu, Chung-Ming, Lee, Yueh-Ting, Wu, Po-Jung, Lee, Wen-Chin, Lee, Chien-Te, Liao, Shang-Chih, Tsai, Kai-Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148756/
https://www.ncbi.nlm.nih.gov/pubmed/37127127
http://dx.doi.org/10.1016/j.ijantimicag.2023.106834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148756/
https://www.ncbi.nlm.nih.gov/pubmed/37127127
http://dx.doi.org/10.1016/j.ijantimicag.2023.106834

Ejemplares similares